Nitric oxide regulates immune cell bioenergetic: A mechanism to understand immunomodulatory functions of nitric oxide-releasing anti-inflammatory drugs

Journal of Immunology

Volumn 173, Issue 2, 2004, Pages 874-882

  Fiorucci, Stefano ^a,c   Mencarelli, Andrea ^a   Distrutti, Eleonora ^a   Baldoni, Monia ^a   Del Soldato, Piero ^b   Morelli, Antonio ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b NicOx SA   (France)

^c POLICLINICO MONTELUCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (2 AMINOETHYL) N (2 AMMONIOETHYL)AMINO]DIAZEN 1 IUM 1,2 DIOLATE; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; ACETYLSALICYLIC ACID DERIVATIVE; ADENOSINE TRIPHOSPHATE; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2 INHIBITOR; CYTOCHROME C OXIDASE; CYTOKINE; GAMMA INTERFERON; GLUCOSE TRANSPORTER 1; HEMOGLOBIN; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LACTIC ACID; NCX 4017; NITRIC OXIDE; PEROXYNITRITE; SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOENERGY; CELL DEATH; CELL PROLIFERATION; CELL RESPIRATION; CITRIC ACID CYCLE; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREACTIVITY; MONOCYTE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; T LYMPHOCYTE;

EID: 3142736598     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.2.874     Document Type: Article

References (49)

1. Plas, D. R., and C. B. Thompson. 2002. Cell metabolism in the regulation of programmed cell death. Trends Endocrinol. Metab. 13:75.
2. Krauss, S., M. D. Brand, and F. Buttgereit. 2001. Signaling takes a breath: new quantitative perspectives on bioenergetics and signal transduction, Immunity 15:497.
3. Buttgereit, F., G. R. Burmester, and M. D. Brand. 2000. Bioenergetics of immune functions: fundamental and therapeutic aspects. Immunol. Today 21:192.
4. Whetton, A. D., G. W. Bazill, and T. M. Dexter. 1984. Haemopoietic cell growth factor mediates cell survival via its action on glucose transport. EMBO J. 3:409.
5. Roos, D., and J. A. Loos. 1970. Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. I. Stimulation by phytohaemagglutinin. Biochim. Biophys. Acta 222:565.
6. Sagone, A. L., Jr., A. F. LoBuglio, and S. P. Balcerzak. 1974. Alterations in hexose monophosphate shunt during lymphoblastic transformation. Cell. Immunol. 14:443.
7. Levene, P. A., and G. M. Meyer. 1912. The action of leukocytes on glucose. J. Biol. Chem. 11:361.
8. Kempner, W. 1939. The nature of leukemic blood cells as determined by their metabolism. J. Clin. Invest. 18:291.
9. Rathmell, J. C., M. G. Vander Heiden, M. H. Harris, K. A. Frauwirth, and C. B. Thompson. 2000. In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol. Cell 6:683.
10. Fauwirth, K. A., J. L. Riley, M. H. Harris, R. V. Parry, J. C. Rathmell, D. R. Plas, R. L. Elstrom, C. H. June, and C. B. Thompson. 2002. CD28 signaling pathway regulates glucose metabolism. Immunity 6:769.
11. DiMauro, S., and E. A. Schon. 2003. Ochondrial respiratory-chain diseases. N. Engl. J. Med. 48:2656.
12. Saadi, S., L. E. Wrenshall, and J. L. Platt. 2002. Regional manifestations and control of the immune system. FASEB J. 16:9.
13. Wingrove, J. A., and P. H. O'Farrell. 1999. Nitric oxide contributes to behavioral, cellular, and developmental responses to low oxygen in Drosophila. Cell 98:105.
14. Semenza, G. L. 1999. Perspectives on oxygen sensing. Cell 98:281.
15. Moncada, S., and J. D. Erusalimsky. 2003. Nitric oxide modulate mitochondrial energy generation and apoptosis? Nat. Rev. Mol. Cell Biol. 3:214.
16. Clementi, E., G. C. Brown, M. Feelisch, and S. Moncada. 1998. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc. Natl. Acad. Sci. USA 95:7631.
17. Borutaite, V., A. Matthias, H. Harris, S. Moncada, and G. C. Brown. 2001. Reversible inhibition of cellular respiration by nitric oxide in vascular inflammation. Am. J. Physiol. Heart Circ. Physiol. 281:H2256.
18. Beltran, B., A. Mathur, M. R. Duchen, J. D. Erusalimsky, and S. Moncada. 2000. The effect of nitric oxide on cell respiration: a key to understanding its role in cell survival or death. Proc. Natl. Acad. Sci. USA 97:14602.
19. Drapier, J. C., and J. B. Hibbs, Jr. 1998. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J. Immunol. 15;140:2829.
20. Stuehr, D. J., and C. F. Nathan. 1989. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1543.
21. Coleman, J. W. 2001. Nitric oxide in immunity and inflammation. Int. Immunopharmacol. 1:1397.
22. Wallace, J. L., L. J. Ignarro, and S. Fiorucci. 2002. Potential cardioprotective actions of NO-releasing aspirin. Nat. Rev. Drug Discov. 1:375.
23. Fiorucci, S. 2001. NO-releasing NSAIDs are caspase inhibitors. Trends Immunol. 22:232.
24. Fiorucci, S., L. Santucci, P. Gresele, R. M. Faccino, P. Del Soldato, and A. Morelli. 2003. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study. Gastroenterology 124:600.
25. Fiorucci, S., A. Mencarelli, A. Meneguzzi, A. Lechi, A. Morelli, P. del Soldato, and P. Minuz. 2002. NCX-4016 (NO-aspirin) inhibits lipopolysaccharide- induced tissue factor expression in vivo: role of nitric oxide. Circulation 106:3120.
26. Fiorucci, S., A. Mencarelli, R. Mannucci, E. Distrutti, A. Morelli, P. del Soldato, and S. Moncada. 2002. NCX-4016, a nitric oxide-releasing aspirin, protects endothelial cells against apoptosis by modulating mitochondrial function. FASEB J. 16:1645.
27. Fiorucci, S., L. Santucci, G. Cirino, A. Mencarelli, L. Familiari, P. D. Soldato, and A. Morelli. 2000. IL-1β converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs. J. Immunol. 165:5245.
28. Fiorucci, S., L. Santucci, E. Antonelli, E. Distrutti, G. Del Sero, O. Morelli, L. Romani, B. Federici, P. Del Soldato, and A. Morelli. 2000. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology 118:404.
29. Mueckler, M., R. C. Hresko, and M. Sato. 1997. Structure, function and biosynthesis of GLUT1. Biochem. Soc. Trans. 25:951.
30. Flescher, E., D. Fossum, P. J. Gray, G. Fernandes, M. J. Harper, and N. Talal. 1991. Aspirin-like drugs prime human T cells: modulation of intracellular calcium concentrations. J. Immunol. 146:2553.
31. Hsia, J., N. Sarin, J. H. Oliver, and A. L. Goldstein. 1989. Aspirin and thymosin increase interleukin-2 and interferon-γ production by human peripheral blood lymphocytes. Immunopharmacology 17:167.
32. Mateo, J., M. Garcia-Lecea, S. Cadenas, C. Hernandez, and S. Moncada. 2003. Regulation of hypoxia-inducible factor-1α by nitric oxide through mitochondria-dependent and -independent pathways. Biochem. J. 376:537.
33. Matata, B. M., and M. Galinanes. 2002. Peroxynitrite is an essential component of cytokines production mechanism in human monocytes through modulation of nuclear factor-κB DNA binding activity. J. Biol. Chem. 277:2330.
34. Radi, R., A. Cassina, R. Hodara, C. Quijano, and L. Castro. 2002. Peroxynitrite reactions and formation in mitochondria. Free Radical Biol. Med. 33:1451.
35. Jozsef, L., C. Zouki, N. A. Petasis, C. N. Serhan, and J. G. Filep. 2002. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation: NF-κB and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc. Natl. Acad. Sci. USA 99:13266.
36. Fiorucci, S., E. Distrutti, A. Menearelli, G. Rizzo, A. R. Di Lorenzo, M. Baldoni, P. Del Soldato, A. Morelli, and J. Wallace. 2004. Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates anti-adhesive properties of NCX-4016 (NO-aspirin) on neutrophil-endothelial cell adherence. J. Pharmacol. Exp. Ther. 309:1174.
37. Paxinou, E., M. Weisse, Q. Chen, J. M. Souza, C. Hertkorn, M. Selak, E. Daikhin, M. Yudkoff, G. Sowa, W. C. Sessa, and H. Ischiropoulos. 2001. Dynamic regulation of metabolism and respiration by endogenously produced nitric oxide protects against oxidative stress. Proc. Natl. Acad. Sci. USA 98:11575.
38. Shikhman, A. R., D. C. Brinson, J. Valbracht, and M. K. Lotz. 2001. Cytokine regulation of facilitated glucose transport in human articular chondrocytes. J. Immunol. 167:7001.
39. Foster, M. W., T. J. McMahon, and J. S. Stamler. 2003. S-nitrosylation in health and disease. Trends Mol. Med. 9:160.
40. Stamler, J. S., S. Lamas, and F. C. Fang. 2001. Nitrosylatiom the prototypic redox-based signaling mechanism. Cell 106:675.
41. Brown, G. C., and C. E. Cooper. 1994. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 356:295.
42. Nugent, C., J. B. Prins, J. P. Whitehead, J. M. Wenworth, V. K. K. Chatterjee, and S. O'Rahilly. 2001. Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane: evidence for involvement of lipooxygenase metabolites and peroxisome proliferator-activator receptor γ. J. Biol. Chem. 276:9149.
43. Karlsson, H., J. W. DePierre, and L. Nassberger. 1997. Energy levels in resting and mitogen-stimulated human lymphocytes during treatment with FK506 or cyclosporin A in vitro. Biochim. Biophys. Acta 1319:301.
44. Avruch, J. 1998. Insulin signal transduction through protein kinase cascades. Mol. Cell. Biochem. 182:31.
45. Gergely, P., Jr., B. Niland, N. Gonchoroff, R. Pullmann, Jr., P. E. Phillips, and A. Perl. 2002. Persistent mitochondrial hyperpolarization, increased reactive oxyygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus. J. Immunol. 169:1092.
46. Kuhnke, A., G. R. Burmester, S. Krauss, and F. Buttgereit. 2003. Bioenergetics of immune cells to assess rheumatic disease activity and efficacy of glucocorticoid treatment. Ann. Rheum. Dis. 62:133.
47. Deepalakshmi, P. D., K. Parasakthy, S. Shanthi, and N. S. Devaraj. 1994. Effect of chloroquine on rat liver mitochondria. Indian J. Exp. Biol. 32:797.
48. Anderson, R., C. E. Van Rensburg, G. K. Joone, and A. Lessing. 1991. Auranofin inactivates hosphofructokinase in human neutrophils, leading to depletion of intracellular ATP and inhibition of superoxide generation and locomotion. Mol. Pharmacol. 40:427.
49. Buttgereit, F., A. Grant, M. Muller, and M. D. Brand. 1994. The effects of methylprednisolone on oxidative phosphorylation in concanavalin-A-stimulated thymocytes: top-down elasticity analysis and control analysis. Eur. J. Biochem. 223:513.